Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: majormember who wrote (2835)	7/24/1999 6:48:00 PM
From: Peter van Steennis	Read Replies (2) \| Respond to of 4140

Skane and all, I have been out of SNRS for some months now as I could not justify the stock value given the FDA status. That said, since much or all of the research was conducted by doctors who owned stock in Sunrise, (not illegal, just seems improper or self serving on its face), I am sure the panel felt "at risk" if they approved the procedure with this knowledge. Imagine what an attorney would do to all of them if his clients eye sight was lost or further impaired. Error on the side of caution. The FDA will also, probably, not approve for the same reason. Sunrise will have to go back to the drawing board and have independent doctors analyze and perhaps interview and test random patients. On another matter, since over 11 millions shares traded Friday, who was doing all the buying? Even shorts had to theoretically buy and then sell to cover their short position. So who ended up with all the stock? Peter